These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 4143056

  • 1. Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
    Stühlinger W, Kourilsky O, Kanfer A, Sraer JD.
    Lancet; 1974 Sep 28; 2(7883):788-9. PubMed ID: 4143056
    [No Abstract] [Full Text] [Related]

  • 2. Letter: Serum-complement levels in haemolytic-uraemic syndrome.
    Monnens L, Hendrickx G, van Wieringen P, van Munster P.
    Lancet; 1974 Aug 03; 2(7875):294. PubMed ID: 4135724
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Persistent activation of C3 in the hemolytic uremic syndrome].
    Gonzalo A, Sarrias J, Alsina J.
    Rev Clin Esp; 1977 May 31; 145(4):281-3. PubMed ID: 866752
    [No Abstract] [Full Text] [Related]

  • 7. Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third component of complement.
    Roodhooft AM, McLean RH, Elst E, Van Acker KJ.
    Pediatr Nephrol; 1990 Nov 31; 4(6):597-9. PubMed ID: 2088459
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Possible C1q bypass loop activation in the haemolytic uraemic syndrome.
    Nolin L, O'Regan S, Pelletier M, Rivard GE, Mongeau JG, Robitaille P.
    Clin Exp Immunol; 1979 Jan 31; 35(1):107-11. PubMed ID: 371879
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome.
    Ahlenstiel-Grunow T, Hachmeister S, Bange FC, Wehling C, Kirschfink M, Bergmann C, Pape L.
    Nephrol Dial Transplant; 2016 Jul 31; 31(7):1114-21. PubMed ID: 27190382
    [Abstract] [Full Text] [Related]

  • 14. [Hemolytic-uremic syndrome, low C-3 and positive ANCA].
    Castellano I, Pereira LF, Gómez-Martino JR, Covarsí A.
    Nefrologia; 2006 Jul 31; 26(1):146-7. PubMed ID: 16649441
    [No Abstract] [Full Text] [Related]

  • 15. Complement evaluation in atypical hemolytic uremic syndrome: current concepts.
    Sethi SK, Jhaveri KD.
    Saudi J Kidney Dis Transpl; 2012 Sep 31; 23(5):1074-6. PubMed ID: 22982929
    [No Abstract] [Full Text] [Related]

  • 16. Adult hemolytic uremic syndrome with renal arteriolar deposition of IgM andC3.
    Hammar SP, Bloomer HA, McCloskey D.
    Am J Clin Pathol; 1978 Sep 31; 70(3):434-9. PubMed ID: 152058
    [Abstract] [Full Text] [Related]

  • 17. Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.
    Ferraris JR, Ferraris V, Acquier AB, Sorroche PB, Saez MS, Ginaca A, Mendez CF.
    Clin Exp Immunol; 2015 Jul 31; 181(1):118-25. PubMed ID: 25677399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does dysregulated complement activation contribute to haemolytic uraemic syndrome secondary to Streptococcus pneumoniae?
    Gilbert RD, Nagra A, Haq MR.
    Med Hypotheses; 2013 Sep 31; 81(3):400-3. PubMed ID: 23786906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.